Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ching-Hon Pui

Showing results (221-230 of 610) with videos related to

Pageof 61
Sort By:
Blood|March 23, 2010
Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemiaPatricia Stow, Laura Key, Xiaohua Chen, et al.
Archives of Physical Medicine and Rehabilitation|May 31, 2011
Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemiaEmily D Joyce, Vikki G Nolan, Kirsten K Ness, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemiaJohn Carl Panetta, Yuri Yanishevski, Ching-Hon Pui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2014
NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual diseaseErin M Sullivan, Sima Jeha, Guolian Kang, et al.
Cancer|November 4, 2009
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemiaHiroto Inaba, Clinton F Stewart, Kristine R Crews, et al.
Pediatric Blood & Cancer|May 30, 2020
Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21Richa Sharma, Matthew M Klairmont, Ashley C Holland, et al.
Blood Advances|April 14, 2023
Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemiaSeth E Karol, Elaine Coustan-Smith, Stanley Pounds, et al.
Pediatric Blood & Cancer|May 1, 2015
Natural killer cell therapy in children with relapsed leukemiaJeffrey E Rubnitz, Hiroto Inaba, Guolian Kang, et al.
AJR. American Journal of Roentgenology|January 21, 2006
MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patternsEvguenia J Karimova, Shesh N Rai, David Ingle, et al.
Clinical Pharmacology and Therapeutics|June 18, 2003
Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemiaThierry Dervieux, Michael L Hancock, Ching-Hon Pui, et al.
Pageof 61

Showing results (221-230 of 610) with videos related to

Sort By:
Pageof 61
Blood|March 23, 2010
Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemiaPatricia Stow, Laura Key, Xiaohua Chen, et al.
Archives of Physical Medicine and Rehabilitation|May 31, 2011
Association of muscle strength and bone mineral density in adult survivors of childhood acute lymphoblastic leukemiaEmily D Joyce, Vikki G Nolan, Kirsten K Ness, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemiaJohn Carl Panetta, Yuri Yanishevski, Ching-Hon Pui, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 5, 2014
NK cell genotype and phenotype at diagnosis of acute lymphoblastic leukemia correlate with postinduction residual diseaseErin M Sullivan, Sima Jeha, Guolian Kang, et al.
Cancer|November 4, 2009
Combination of cladribine plus topotecan for recurrent or refractory pediatric acute myeloid leukemiaHiroto Inaba, Clinton F Stewart, Kristine R Crews, et al.
Pediatric Blood & Cancer|May 30, 2020
Integrative genomic analysis of B-lymphoblastic lymphoma with intrachromosomal amplification of chromosome 21Richa Sharma, Matthew M Klairmont, Ashley C Holland, et al.
Blood Advances|April 14, 2023
Clinical impact of minimal residual disease in blood and bone marrow of children with acute myeloid leukemiaSeth E Karol, Elaine Coustan-Smith, Stanley Pounds, et al.
Pediatric Blood & Cancer|May 1, 2015
Natural killer cell therapy in children with relapsed leukemiaJeffrey E Rubnitz, Hiroto Inaba, Guolian Kang, et al.
AJR. American Journal of Roentgenology|January 21, 2006
MRI of knee osteonecrosis in children with leukemia and lymphoma: Part 2, clinical and imaging patternsEvguenia J Karimova, Shesh N Rai, David Ingle, et al.
Clinical Pharmacology and Therapeutics|June 18, 2003
Antagonism by methotrexate on mercaptopurine disposition in lymphoblasts during up-front treatment of acute lymphoblastic leukemiaThierry Dervieux, Michael L Hancock, Ching-Hon Pui, et al.
Pageof 61